# Efficacy and Safety of Combination Therapy of Moderate-intensity Statin and Ezetimibe Compared to High-intensity Statin

> **NCT04080310** · PHASE4 · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 270 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DRUG:** Efficacy and safety of combination therapy of moderate-intensity statin and ezetimibe compared to high-intensity statin

## Key facts

- **NCT ID:** NCT04080310
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-15
- **Primary completion:** 2019-06-15
- **Final completion:** 2019-09-17
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2020-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04080310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04080310, "Efficacy and Safety of Combination Therapy of Moderate-intensity Statin and Ezetimibe Compared to High-intensity Statin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04080310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*